6 Key Estimations on Colorectal Cancer Diagnostics Market Reveals Growth Facts, Trends and Future Forecast till 2022

Dublin 2, Ireland, 2018-Mar-15 — /EPR Network/ — A fresh study, covering “Colorectal Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the Retail & Consumer Goods Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the “Colorectal Cancer Diagnostics Market”.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=70

The global colorectal cancer diagnostics market is anticipated to exhibit an impressive expansion at a CAGR of 8.5% during the forecast period 2017 to 2022, according to a report by Fact.MR. Global revenues from the market is projected to surpass US$ 2,000 Mn by 2022-end.

According to the World Cancer Research Fund, colorectal cancer forms the third-most occurring type of cancer across the globe. In 2012, over 1 Mn cases of colorectal cancer were diagnosed. Majority of these cases were reported across developed economies, and this is further estimated to exceed in the near future. This rise in incidences of colorectal cancer has boosted demand for its diagnostics, treatment, and therapeutics worldwide. However, the number of deaths owing to colorectal cancer has been witnessing a decline since recent past, owing to the awareness spread by the American Cancer Society. The introduction of more effective diagnostics, and development of screening methods are further expected to drive growth of the global colorectal cancer diagnostics market.

Introduction of Effective Diagnosis Tests and Development of Screening Methods to Drive the Market Growth

The World Cancer Research Fund estimates the colorectal cancer to be the third-most occurring form of cancer around the world. In 2012, more than 1 Mn people were diagnosed with colorectal cancer. Majority of these were reported in the developed economies, and this is anticipated to surge in the near future. These incidences of colorectal cancer have boosted demand for their diagnostics worldwide. In addition, the number of deaths caused by colorectal cancer has witnessed a decline over the recent past, on the back of awareness spread by American Cancer Society (ACS). Introduction of effective instruments, along with the development of screening methods are estimated to further propel growth of the global market for colorectal cancer diagnostics.

The market for colorectal cancer diagnostics in Asia Pacific excluding Japan (APEJ) is estimated to exhibit the fastest expansion throughout the forecast period. Revenue from the market in Middle East & Africa (MEA) will continue to be sluggish during the forecast period. North America will remain the most lucrative region for colorectal cancer diagnostics. North America’s colorectal cancer diagnostics market is anticipated to account for nearly US$ 800 Mn in revenues by 2022-end. Markets in Europe and North America are estimated to register a parallel expansion at a CAGR of 8.6% through 2022.

FOB Tests will Continue to Witness Largest Adoption for Colorectal Cancer Diagnostics

FOB tests will remain the largest adopted tests for colorectal cancer diagnostics across the globe. In addition, FOB tests in the global colorectal cancer diagnostics market will account for the largest revenues, followed by CTC tests. The immunochemistry tests will register the highest CAGR in the market through 2022. However, BRAF tests will account for the lowest revenues in the global market for colorectal cancer diagnostics throughout the forecast period.

Based on end-users, even though hospital-associated labs are estimated to remain sought-after for colorectal cancer diagnostics, cancer research institutes will register the fastest expansion through 2022. Hospital-associated labs in the global colorectal cancer diagnostics market are estimated to account for nearly US$ 1,000 Mn in revenues by 2022-end. In addition, independent diagnostic laboratories will remain the second largest end-users of colorectal cancer diagnostics in the global market.

Browse Full Report with TOC- https://www.factmr.com/report/70/colorectal-cancer-diagnostics-market

Table of Content:

1. Global Colorectal Cancer Diagnostics Market – Executive Summary

2. Global Colorectal Cancer Diagnostics Market Overview

2.1. Introduction

2.1.1. Global Colorectal Cancer Diagnostics Market Taxonomy

2.1.2. Global Colorectal Cancer Diagnostics Market Definition

2.2. Global Colorectal Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022

2.2.1. Global Colorectal Cancer Diagnostics Market Y-o-Y Growth

2.3. Global Colorectal Cancer Diagnostics Market Dynamics

2.4. Supply Chain

2.5. Epidemiology

2.6. List of Distributors

2.7. Average Pricing Analysis

2.8. Regulations

2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Colorectal Cancer Diagnostics Market Analysis and Forecast By Test Type

3.1. Global Colorectal Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022

3.1.1. FOB Colorectal Cancer Diagnostics Market Size and Forecast, 2012-2022

3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region

3.1.1.3. Y-o-Y growth Comparison, By Region

3.1.2. CTC Tests Colorectal Cancer Diagnostics Market Size and Forecast, 2012-2022

3.1.2.1. Revenue (US$ Mn) Comparison, By Region

3.1.2.2. Market Share Comparison, By Region

3.1.2.3. Y-o-Y growth Comparison, By Region

Continued….

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=70

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/